FDA endorses Herceptin for advanced breast cancer
FDA advisers recommend Genentech’s Herceptin for patients with tumors driven by HER2/neu, offering extended life for about 30 percent of cases. They also support tamoxifen for high risk women, with cautions on side effects. final decisions due by November.
MENTIONED IN THIS ARTICLE
Bethesda
Food and Drug Administration
FDA
Dennis Slamon
University of California, Los Angeles
Herceptin
Genentech Inc
Scientists Find Risk in Genetic Engineering
Environmentalists warn after scientists report that genetic engineering could heighten weed resilience and spread traits to other plants. The study suggests herbicide resistance may spread, leading to heavier spraying or use of less safe herbicides by farmers.
MENTIONED IN THIS ARTICLE
Charles ‘Margulis
Feds approve morning-after pill marketing
U S officials grant the first permit to advertise and sell regular birth control pills as morning-after pills to prevent pregnancy after unprotected sex The pills show 75 percent effectiveness within three days while standard pills are 99 percent effective when used correctly Doctors note underuse due to lack of patient awareness and provider inquiry The measure distinguishes morning-after use from RU 486 abortion pills.
MENTIONED IN THIS ARTICLE
Washington
Felicia Stewart
Kaiser Family Foundation
Pancreas link found to cystic fibrosis gene in pancreatitis
Two studies reported in the New England Journal of Medicine connect the CFTR gene to chronic pancreatitis, especially in non alcoholics. Researchers estimate the gene may influence about 10 to 15 percent of cases, with one third to one half of unexplained pancreatitis tied to CFTR mutations.
MENTIONED IN THIS ARTICLE
Boston
Jonathan A. Cohn
Duke University
Durham
N.C
Cohn
Nicholas Sharer
Manchester Royal Infirmary
England
New England Journal of Medicine
Also Mentioned on This Page
The
Associated Press
Stephen's Furniture, Inc
Odessa
Feds
Nera YeNct
ORIG
Bealls
Music City Mall
Live Oak Plaza
One Energy Square
West County Plaza